The official document of the OTC Center informed the company that it will be officially listed on the OTC market on August 18, 2017. In the future, in addition to performance and profit as important goals, the company’s various R&D projects and product development will continue to generate value-added benefits, and continue to expand the business scope, give back to the society with R&D results, and benefit medical patients, so as to achieve the company’s vision and core value of Uni Pharma.
English
English
